Quality by design approach for viral clearance by protein a chromatography
暂无分享,去创建一个
Min Zhang | Kurt A Brorson | Melody Trexler-Schmidt | Philip Lester | Min Zhang | K. Brorson | G. Miesegaes | Lenore Norling | Qi Chen | George R Miesegaes | Bin Yang | P. Lester | Michael Lee | Daniel Coleman | Bin Yang | Daniel Coleman | Melody Trexler-Schmidt | Qi Chen | L. Norling | Michael Lee
[1] Chintan Dalwadi,et al. Implementation of "Quality by Design (QbD)" Approach for the Development of 5-Fluorouracil Loaded Thermosensitive Hydrogel. , 2016, Current drug delivery.
[2] V. Sisodiya,et al. Studying host cell protein interactions with monoclonal antibodies using high throughput protein A chromatography. , 2012, Biotechnology journal.
[3] Anurag Rathore. Implementation of Quality by Design (QbD) for Biopharmaceutical Products. , 2010, PDA journal of pharmaceutical science and technology.
[4] R. Bayer,et al. Recovery and purification process development for monoclonal antibody production , 2010, mAbs.
[5] S. Lute,et al. Analysis of viral clearance unit operations for monoclonal antibodies , 2010, Biotechnology and bioengineering.
[6] K. Brorson,et al. Proceedings of the 2009 Viral Clearance Symposium. , 2010, Developments in biologicals.
[7] S. Lute,et al. Multiplex RT Q-PCR assay for simultaneous quantification of three viruses used for validation of virus clearance by biopharmaceutical production. , 2009, Biologicals : journal of the International Association of Biological Standardization.
[8] Kurt Brorson,et al. A Novel, Q‐PCR Based Approach to Measuring Endogenous Retroviral Clearance by Capture Protein A Chromatography , 2009, Biotechnology and bioengineering.
[9] A. Rathore,et al. Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.
[10] Anurag S. Rathore,et al. Quality by design for biopharmaceuticals : principles and case studies , 2009 .
[11] Kurt Brorson,et al. Robustness of virus removal by protein A chromatography is independent of media lifetime. , 2008, Journal of chromatography. A.
[12] A. Rathore,et al. PDA workshop on "Quality by Design for Biopharmaceuticals: Concepts and Implementation", May 21-22, 2007, Bethesda, Maryland. , 2008, PDA journal of pharmaceutical science and technology.
[13] Brian Hubbard,et al. Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] Sanchayita Ghose,et al. Binding capacity differences for antibodies and Fc‐fusion proteins on protein A chromatographic materials , 2007, Biotechnology and bioengineering.
[15] Sanchayita Ghose,et al. Protein A Affinity Chromatography for Capture and Purification of Monoclonal Antibodies and Fc-Fusion Proteins: Practical Considerations for Process Development , 2006 .
[16] S. Lute,et al. Normal‐flow virus filtration: detection and assessment of the endpoint in bioprocessing , 2005, Biotechnology and applied biochemistry.
[17] Liming Shi,et al. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification , 2004, Biotechnology and bioengineering.
[18] Alois Jungbauer,et al. Engineering protein A affinity chromatography. , 2004, Current opinion in drug discovery & development.
[19] Alois Jungbauer,et al. Comparison of protein A affinity sorbents. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] Kurt Brorson,et al. Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. , 2003, Biotechnology and bioengineering.
[21] K. Brorson,et al. Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. , 2003, Journal of chromatography. A.
[22] J. Vennari,et al. Detection of minute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of Mammalian cell substrate derived biotherapeutics. , 2002, Biologicals : journal of the International Association of Biological Standardization.
[23] Kurt Brorson,et al. Impact of cell culture process changes on endogenous retrovirus expression. , 2002, Biotechnology and bioengineering.
[24] M Vanderlaan,et al. Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes , 2001, Biotechnology & genetic engineering reviews.
[25] C. Fautz,et al. Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture. , 2000, Biologicals : journal of the International Association of Biological Standardization.
[26] M Vanderlaan,et al. Performance comparison of Protein A affinity‐chromatography sorbents for purifying recombinant monoclonal antibodies , 1999, Biotechnology and applied biochemistry.
[27] Y. Xu,et al. A real time quantitative PCR-based method for the detection and quantification of simian virus 40. , 1999, Biologicals : journal of the International Association of Biological Standardization.